DICOM Grid has been contracted by Greater Houston Healthconnect to electronically deliver medical images to area hospitals and physicians at the point-of-care.
April 7, 2014 — A new multicenter clinical trial seeks to offer men another option for treating prostate cancer, one that physicians hope will treat cancers with fewer side effects. The treatment involves the use of MRI (magnetic resonance imaging) to guide focused beams of ultrasound energy to the prostate.
April 7, 2014 — Cianna Medical announced the results of a retrospective study of breast cancer patients with ductal carcinoma in situ (DCIS) treated with SAVI breast brachytherapy. Researchers reported excellent local control, with recurrence rates that appear to be equivalent to those expected for whole breast irradiation (WBI) with similar follow-up.
Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and effective storage lockers for harmful isotopes that emit ionizing radiation for treating tumors.
The American College of Radiology (ACR) and Society of Breast Imaging (SBI) agree with statements made by Pace and Keating, in their article to be published in the Journal of the American Medical Association (JAMA), that women should discuss mammography with their doctor and breast cancer diagnosis and treatment may one day be more individualized.
If you enjoy this content, please share it with a colleague
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopamidol (Isovue) 370 mg I/ml during peripheral arteriography.
If you enjoy this content, please share it with a colleague
April 3, 2014 — A new paper published by a joint U.S. and Canadian team in PLOS One suggests SPECT (single-photon emission computed tomography) is useful in both identifying and guiding treatment for those with traumatic brain injury (TBI).
April 3, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the Cios Alpha, a new mobile C-arm system with flat-panel detector that boasts a power output of 25 kilowatts (kW) and has a field of view (FoV) that is up to 25 percent larger than conventional C-arms.
